Elizabeth C. Paver

479 total citations
15 papers, 322 citations indexed

About

Elizabeth C. Paver is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Elizabeth C. Paver has authored 15 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Elizabeth C. Paver's work include Cutaneous Melanoma Detection and Management (5 papers), Melanoma and MAPK Pathways (3 papers) and Head and Neck Surgical Oncology (2 papers). Elizabeth C. Paver is often cited by papers focused on Cutaneous Melanoma Detection and Management (5 papers), Melanoma and MAPK Pathways (3 papers) and Head and Neck Surgical Oncology (2 papers). Elizabeth C. Paver collaborates with scholars based in Australia, Netherlands and Singapore. Elizabeth C. Paver's co-authors include Ruta Gupta, Jane E. Dahlstrom, Richard A. Scolyer, Wendy A. Cooper, Andrew J. Colebatch, Peter M. Ferguson, Sandra A. O’Toole, Lyndal Anderson, Trina Lum and Joo‐Shik Shin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Journal of the American Academy of Dermatology.

In The Last Decade

Elizabeth C. Paver

15 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth C. Paver Australia 7 186 82 76 67 51 15 322
Nooshin Hashemi Sadraei United States 10 199 1.1× 130 1.6× 66 0.9× 42 0.6× 60 1.2× 30 321
Javier Valdivia Spain 8 152 0.8× 91 1.1× 70 0.9× 100 1.5× 34 0.7× 26 321
Laurenz Vormittag Austria 11 153 0.8× 95 1.2× 73 1.0× 53 0.8× 27 0.5× 22 345
George Blumenschein United States 10 215 1.2× 87 1.1× 90 1.2× 38 0.6× 37 0.7× 20 336
Ajit Paintal United States 12 99 0.5× 91 1.1× 128 1.7× 65 1.0× 31 0.6× 24 333
Wanxing Chai‐Ho United States 6 201 1.1× 66 0.8× 76 1.0× 35 0.5× 85 1.7× 24 298
Franz J. Hilke Germany 10 114 0.6× 62 0.8× 68 0.9× 28 0.4× 40 0.8× 15 276
Eduardo Breda Portugal 12 184 1.0× 80 1.0× 71 0.9× 86 1.3× 27 0.5× 31 331
Wenxiao Jia China 10 219 1.2× 95 1.2× 157 2.1× 42 0.6× 57 1.1× 25 374
Hirofumi Ohmura Japan 11 271 1.5× 117 1.4× 95 1.3× 47 0.7× 138 2.7× 30 425

Countries citing papers authored by Elizabeth C. Paver

Since Specialization
Citations

This map shows the geographic impact of Elizabeth C. Paver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth C. Paver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth C. Paver more than expected).

Fields of papers citing papers by Elizabeth C. Paver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth C. Paver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth C. Paver. The network helps show where Elizabeth C. Paver may publish in the future.

Co-authorship network of co-authors of Elizabeth C. Paver

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth C. Paver. A scholar is included among the top collaborators of Elizabeth C. Paver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth C. Paver. Elizabeth C. Paver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Paver, Elizabeth C., et al.. (2023). A sheep in wolf's clothing: Agminated blue naevi masquerading as in‐transit melanoma metastases. Australasian Journal of Dermatology. 64(2). e196–e199. 1 indexed citations
2.
Najjar, Reabal, et al.. (2023). Dissecting a diagnostic enigma: Hypertension in a young patient from an organ of Zuckerkandl paraganglioma. SHILAP Revista de lepidopterología. 11(10). e8061–e8061. 1 indexed citations
3.
Gide, Tuba N., Elizabeth C. Paver, Nurudeen A. Adegoke, et al.. (2023). Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies. OncoImmunology. 12(1). 2261248–2261248. 20 indexed citations
4.
Paver, Elizabeth C. & Adrienne Morey. (2023). Biomarkers and biomarker validation: a pathologist's guide to getting it right. Pathology. 56(2). 147–157. 7 indexed citations
5.
Paver, Elizabeth C., Tasnia Ahmed, Hazel Burke, et al.. (2023). Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma. JAMA Dermatology. 159(12). 1359–1359. 4 indexed citations
6.
Rawson, Robert V., Alison J. Potter, Elizabeth C. Paver, et al.. (2022). Melanomas in children and adolescents: Clinicopathologic features and survival outcomes. Journal of the American Academy of Dermatology. 88(3). 609–616. 7 indexed citations
7.
Colebatch, Andrew J., Elizabeth C. Paver, Ismael A. Vergara, et al.. (2022). Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma. Pathology. 54(5). 533–540. 5 indexed citations
8.
Paver, Elizabeth C., et al.. (2022). Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient. Case Reports in Dermatology. 14(2). 127–131. 3 indexed citations
9.
Potter, Alison J., Elizabeth C. Paver, Robert V. Rawson, et al.. (2022). 798P NeoTrio – Optimal neoadjuvant (NAT) sequencing of anti-PD-1 and BRAF targeted therapy (TT) in BRAF mutant stage III melanoma: Results of histopathological analysis. Annals of Oncology. 33. S909–S909. 1 indexed citations
10.
Paver, Elizabeth C., Sandra O’Toole, Xin Cheng, Annabelle Mahar, & Wendy A. Cooper. (2021). Updates in the molecular pathology of non-small cell lung cancer. Seminars in Diagnostic Pathology. 38(5). 54–61. 14 indexed citations
11.
Jiang, Xuan‐Zhao, Jiayu Wen, Elizabeth C. Paver, et al.. (2021). H2A.B is a cancer/testis factor involved in the activation of ribosome biogenesis in Hodgkin lymphoma. EMBO Reports. 22(8). e52462–e52462. 13 indexed citations
12.
Paver, Elizabeth C., Wendy A. Cooper, Andrew J. Colebatch, et al.. (2020). Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation. Pathology. 53(2). 141–156. 170 indexed citations
13.
O’Toole, Sandra, et al.. (2020). A case of an asymptomatic sacrococcygeal teratoma diagnosed in adulthood. Journal of Surgical Case Reports. 2020(11). rjaa462–rjaa462. 1 indexed citations
14.
Paver, Elizabeth C., et al.. (2019). Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV. Pathology. 52(2). 179–191. 74 indexed citations
15.
Paver, Elizabeth C., et al.. (2019). Prognostic Utility of CDX2 and PD-L1 in Rectal Cancer. Applied immunohistochemistry & molecular morphology. 28(6). e53–e53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026